MEDP Medpace Holdings, Inc.
Healthcare$429.11-0.85%ClosedMarket Cap: $12.26B
As of 2026-05-26
Valuation
P/E (TTM)
31.99
PEG
2.77
P/B
20.58
P/S
4.62
EV/EBITDA
20.44
DCF Value
$422.32
FCF Yield
6.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
29.1%
Operating Margin
21.0%
Net Margin
17.2%
ROE
120.9%
ROA
21.6%
ROIC
56.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $706.6M | 27.8% | $141.5M | $123.9M | $— | — |
| Q4 null | $708.5M | 29.0% | $153.3M | $135.1M | $— | — |
| FY null | $2.53B | 30.1% | $534.9M | $451.1M | $— | — |
| Q3 null | $659.9M | 29.8% | $141.8M | $111.1M | $— | — |
| Q2 null | $603.3M | 29.8% | $126.3M | $90.3M | $— | — |
| Q1 null | $558.6M | 31.9% | $113.5M | $114.6M | $— | — |
| Q4 null | $536.6M | 33.2% | $125.4M | $117.0M | $— | — |
| FY null | $2.11B | 31.1% | $446.9M | $404.4M | $— | — |
| Q3 null | $533.3M | 31.7% | $112.3M | $96.4M | $— | — |
| Q2 null | $528.1M | 29.1% | $105.2M | $88.4M | $— | — |
| Q1 null | $511.0M | 30.4% | $104.1M | $102.6M | $— | — |
| Q4 2023 | $498.4M | 27.4% | $87.3M | $78.3M | $2.46 | — |